Douglas Schirle
Analyst · Carl M. Hennig
Thank you, Didier. For the fiscal year ended March 31, 2019, we reported net income of $163,000 or $0.01 per diluted share and net revenues of $51.5 million compared to net loss of $4.5 million or $0.21 per diluted share on net revenues of $42.6 million in the fiscal year ended March 31, 2018. Gross margin was 61.4% compared to 52.6% in the prior year. Gross margin improvement for the full year was primarily due to product mix. Total operating expenses were $31.8 million in fiscal 2019, an increase of 18.3% from $26.9 million in fiscal 2018. Research and development expenses were $21.4 million compared to $17 million from the prior fiscal year. And selling, general and administrative expenses were $10.5 million compared to $9.9 million in fiscal 2018. The increase in research and development expenses was primarily due to development of the APU, including an expense of approximately $1 million related to a nonproduction mask set for the initial APU process, which we incurred in the second quarter -- second fiscal quarter ended September 30, 2018. For the fourth quarter fiscal 2019, we reported a net loss of $102,000 or $0.00 per diluted share, on net revenues of $12.7 million compared to net income of $265,000 or $0.01 per diluted share, on net revenues of $11.2 million in the fourth quarter of fiscal 2018, and net income of $2.3 million or $0.10 per diluted share, on net revenues of $14.7 million in the quarter for fiscal 2019 ended December 31, 2018. Gross margin was 61.2% compared to 56.2% in the prior year period and 68.3% in the preceding third quarter. Total operating expenses in the fourth quarter of fiscal 2019 were $8.1 million compared to $6.4 million in the fourth quarter of fiscal 2018 and $7.8 million in the preceding third quarter. Research and development expenses were $5.6 million in the fourth quarter of fiscal 2019 compared to $4.3 million in the prior year period and $5.2 million in the preceding third quarter. Selling, general and administrative expenses were $2.6 million compared to $2.1 million in the quarter ended March 31, 2018, and flat sequentially from $2.6 million in the preceding quarter. Fourth quarter fiscal 2019 operating loss was $365,000 compared to an operating loss of $111,000 a year ago, and operating income of $2.2 million in the prior quarter. The fourth quarter fiscal 2019 net loss included interest and other income of $186,000 and the tax benefit of $77,000 compared to $109,000 in interest and other income and a tax benefit of $267,000 a year ago. In the preceding quarter, net income included interest and other income of $96,000 and a tax provision of $70,000. Total fourth quarter fiscal 2019 pretax stock-based compensation expense was $580,000 compared to $549,000 in the comparable quarter a year ago and $592,000 in the prior quarter. At March 31, 2019, we had $61.8 million in cash, cash equivalents and short-term investments and $9 million in long-term investments compared to $58.4 million in cash, cash equivalents and shot-term investments and $7.9 million in long-term investments at March 31, 2018. Looking ahead to the first quarter of 2020, we anticipate net revenues in the range of $12.3 million to $13.3 million with a gross margin of approximately 62% to 64%. Operator, at this point, we'll open the call to Q&A